Revolutionizing Pharmacoeconomic Evaluations Ne...

By João L. Carapinha

July 22, 2025

The Zorginstituut Nederland (Dutch National Health Care Institute) has introduced a significant reform in the pharmacoeconomic evaluations Nederland framework. The changes are outlined in a concept report detailing adjustments to structure and con...
Model Type and Its Impact on Pneumococcal Vaccine Cost-Effectiveness in Germany
MAF Test Breast Cancer: Revolutionizing Personalized Treatment in Spanish Onc...
NICE’s Ribociclib Breast Cancer Guidance: A New Era for High-Risk Patie...
Efficacy and Insights of Transdiagnostic Mental Health Apps for Depression an...
Elderly Care Costs 2025: Rising Financial Pressures in Dutch Health Services
Talquetamab Multiple Myeloma: Impact, Evidence, and Policy Considerations
Masitinib Prostate Cancer Trial Gains FDA and EMA Approval for Phase 3 Study
10-Year Health Plan: Transforming England’s NHS for the Future
EU Life Sciences Strategy: Paving the Way for Europe’s Leadership by 2030
Ticagrelor Data Integrity Under Fire: Scrutiny Reveals Flaws in Key Clinical ...
The Value of Self-Care in Public Health: Insights and Implications for Europe
Pharma Ad Spending Trends: Insights from the Top 10 Drug Advertisers of 2024